Hosted on MSN3d
New Stanford Study: This Nutrient Helps Prevent Cancer, But Only 10% of Americans Get Enough
It famously helps to cleanse the system of toxins—and even affects how your genes operate, according to California ...
TMCnet3d
Mevion Delivers First-Ever FIT Compact Proton Therapy System to Stanford Health Care
Mevion Medical Systems, the leader in compact proton therapy solutions, proudly announces the delivery of its first MEVION ...
What to know about genetic testing for cancer, and when to request it
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
UC San Francisco7d
Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48
In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...
Hosted on MSN9d
Stanford Medicine's AI Model Accurately Predicts Cancer Prognoses, Treatment Efficacy
The model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...
HealthLeaders Media15d
Unique Stanford Medicine-designed AI predicts cancer prognoses, responses to treatment
A new artificial intelligence tool developed at Stanford Medicine combines data from medical images with text to predict cancer prognoses and treatment responses.
Cancer Research16d
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer
12Memorial Sloan Kettering Cancer Center, New York City, New York. *Corresponding Author: Adam J. Schoenfeld, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. E-mail: ...
The New York Times22d
How Much Alcohol Does It Take to Raise Your Cancer Risk?
The surgeon general cautioned the public on Friday that even light or moderate drinking is harmful. By Nina Agrawal and Katie Mogg The surgeon general of the U.S. Public Health Service warned on ...
Live Science23d
Healthy breast cells can look like invasive cancer, complicating early diagnosis
"This was very unexpected," study co-author Nicholas Navin, a professor at the University of Texas' MD Anderson Cancer Center, told Live Science in an email. "We would have classified these cells ...